Legend Biotech Corporation (NASDAQ:LEGN) Q2 2025 Earnings Call Transcript
Legend Biotech Corporation (NASDAQ:LEGN) Q2 2025 Earnings Call Transcript August 11, 2025Legend Biotech Corporation misses on earnings expectations.
Legend Biotech Corporation (LEGN)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Hillhouse Capital Management Lei Zhang | 5,984,550 | $212,391,680 | 6.84% | |
| 2. | Suvretta Capital Management Aaron Cowen | 3,774,009 | $133,939,579 | +1% | 4.04% |
| 3. | Deerfield Management James E. Flynn | 2,962,338 | $105,133,376 | +70% | 1.91% |
| 4. | Braidwell LP Alex Karnal | 2,542,104 | $90,219,271 | -15% | 3.09% |
| 5. | Balyasny Asset Management Dmitry Balyasny | 947,633 | $33,631,495 | +372% | 0.05% |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 25,670,311 | $911,039,337 | 0.05% | |
| 2. | 6,472,547 | $229,710,688 | 0.96% | |
| 3. | 4,248,568 | $150,781,678 | 0% | |
| 4. | 2,122,268 | $75,319,291 | 0.11% | |
| 5. | 2,092,732 | $74,276,211 | 0.04% |
News See All
H.C. Wainwright Maintains a Buy on Legend Biotech (LEGN) With a $75 Price Target
Legend Biotech Corporation (NASDAQ:LEGN) is one of the 13 Best Pharma Stocks to Buy According to Wall Street Analysts. On July 2, analyst Mitchell Kapoor from H.C.
13 Best Pharma Stocks to Buy According to Wall Street Analysts
On June 24, Jared Holz, Mizuho's healthcare strategist, appeared on CNBC's 'Fast Money' to talk about competition in the obesity drug space.
Legend Biotech Corporation (NASDAQ:LEGN) Q1 2025 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Legend Biotech’s First Quarter 2025 Earnings Call. At this time, all participants are in a listen-only mode.
20 Takeover Rumors Hedge Funds Are Buying
Hedge funds tend to pile up on a stock that gains or is expected to gain positive attention in a market.
Legend Biotech Corporation (NASDAQ:LEGN) Q4 2024 Earnings Call Transcript
Operator: Good day, and welcome to the Legend Biotech Fourth Quarter and Full-Year 2024 Earnings Call. At this time, all participants are in a listen-only mode.
10 Oversold Pharma Stocks to Buy According to Analysts
On February 20, Emily Field, Head of European Pharma Research at Barclays, appeared on CNBC to discuss the dynamics of the pharmaceutical sector, the impact of US tariffs, and the performance of obesity...
Market Concerns Put Pressure on Legend Biotech Corporation (LEGN) Shares
Meridian Funds, managed by ArrowMark Partners, released its “Meridian Contrarian Fund” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here.
10 Best Mid-Cap Growth Stocks to Buy According to Analysts
Investing in mid-cap growth stocks has long been a favoured strategy for investors looking to strike a balance between the stability of large-cap companies and the high-growth potential of smaller firms...
12 Best Healthcare Stocks to Buy According to Analysts
McKinsey reported that, since 2019, the US healthcare industry witnessed significant financial pressure.